Logo

T2 Biosystems

T2 Biosystems Gets FDA 510(k) Clearance for Biothreat Panel

The clearance allows the firm to immediately begin marketing an assay that simultaneously detects six biothreat pathogens directly from blood.

In Brief This Week: Labcorp; T2 Biosystem; MiRxes; Accelerate Diagnostics; and More

News items for the week of Aug. 7, 2023.  

In Brief This Week: Quest Diagnostics; T2 Biosystems; OraSure Technologies; DermTech; and More

News items for the week of July 31, 2023.  

In Brief This Week: AACC; Siemens Healthineers; Bio-Rad; T2 Biosystems; DermTech; More

News items for the week of July 17, 2023.  

In Brief This Week: Labcorp; T2 Biosystems; Thermo Fisher Scientific; Bio-Techne; More

News items for the week of July 10, 2023.  

Jun 30, 2023

In Brief This Week: T2 Biosystems; Aspira Women's Health; VolitionRx; ATCC; BARDA; Devyser

Jun 9, 2023

T2 Biosystems, Vanderbilt University Medical Center Partner on Prospective Bacterial Sepsis Dx Study

Jun 9, 2023

In Brief This Week: CAP, T2 Biosystems, Siemens Healthineers, DiaSorin, More

May 30, 2023

Top Five Articles on 360Dx Last Week: T2 Biosystems Layoffs; Diasorin Partners With MeMed; More

May 23, 2023

T2 Biosystems Lays off 30 Percent of Workforce as Q1 Revenues Drop 71 Percent

Mar 30, 2023

Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium

Mar 17, 2023

In Brief This Week: PerkinElmer, Roche, T2 Biosystems, Co-Diagnostics, More

Mar 13, 2023

Top Five Articles on 360Dx Last Week: Outlook for COVID-Testing Firms; FDA LDT Regulation; and More

Mar 3, 2023

T2 Biosystems Readies Biothreat Panel for FDA Submission While Keeping Eye on Sepsis Market
Premium

Feb 15, 2023

T2 Biosystems Prices $12M Public Offering

Jan 27, 2023

In Brief This Week: Fujifilm, BD, PerkinElmer, OpGen, More

Nov 11, 2022

Earnings Roundup: T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen

Nov 7, 2022

HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects

Nov 1, 2022

T2 Biosystems Regains Compliance with Nasdaq Listing Requirement

Oct 14, 2022

Canaccord Downgrades T2 Biosystems to Hold

Oct 12, 2022

T2 Biosystems Effects Reverse Stock Split, Reports 50 Percent Drop in Preliminary Q3 Revenues

Sep 29, 2022

BARDA Provides Additional $3.7M to T2 Biosystems Under Contract Option

Aug 30, 2022

T2 Biosystems Regains Nasdaq Listing Requirements

Jul 15, 2022

In Brief This Week: Centogene, T2 Biosystems, Labcorp, More

Jul 6, 2022

T2 Biosystems Reports Preliminary Drop in Q2 Revenues, Cuts Workforce